Cervical adenocarcinoma resembling breast lobular carcinoma: A hitherto undescribed variant of primary cervical adenocarcinoma

International Journal of Gynecological Pathology

Volumn 29, Issue 6, 2010, Pages 594-599

  Mansor, Sorsiah ^a   McCluggage, W Glenn ^a  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

Adenocarcinoma; Breast lobular carcinoma; Cervix; Immunohistochemistry

Indexed keywords

ANTINEOPLASTIC AGENT; CA 125 ANTIGEN; PROTEIN P16; UVOMORULIN;

ABDOMINAL HYSTERECTOMY; ADENOCARCINOMA; ADULT; ARTICLE; BIOPSY; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER MORPHOLOGY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CASE REPORT; COLPOSCOPY; DISTANT METASTASIS; DYSKARYOSIS; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OMENTECTOMY; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN DEPLETION; SALPINGOOOPHORECTOMY; TUMOR DIAGNOSIS; TUMOR DIFFERENTIATION; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VAGINAL HYSTERECTOMY;

ADENOCARCINOMA; ADULT; BREAST NEOPLASMS; CARCINOMA, LOBULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; UTERINE CERVICAL NEOPLASMS;

EID: 78149280568     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/PGP.0b013e3181e36337     Document Type: Article

References (18)

1. Zheng T, Holford TR, Ma Z, et al. The continuing increase in adenocarcinoma of the uterine cervix: a birth cohort phenomenon. Int J Epidemiol 1996;25:252-8.
2. Young RH, Clement PB. Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis. Histopathology 2002;41:1080-8.
3. McCluggage WG. Endocervical glandular lesions: controversial aspects and ancillary techniques. J Clin Pathol 2003;56: 164-73.
4. Kojima A, Mikami Y, Sudo T, et al. Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix. Am J Surg Pathol 2007; 31:664-72.
5. McCluggage WG, Shah R, Connolly LE, et al. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2. Int J Gynecol Pathol 2007;27:92-100.
6. Kato K, Suzuka K, Ozaki T, et al. Primary hepatoid adenocarcinoma of the uterine cervix. Int J Gynecol Cancer 2007;17:1150-4.
7. Houghton O, Jamison J, Wilson R, et al. p16 immuno-reactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection. Histopathology. In press.
8. Silva EG, Deavers MT, Malpica A. Undifferentiated carcinoma of the endometrium: a review. Pathology 2007; 39:134-8.
9. Silva EG, Deavers MT, Bodurka DC, et al. Association of low grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma? Int J Gynecol Pathol 2006;25:52-8.
10. O'Neill CJ, McCluggage WG. p16 expression in the female genital tract and its value in diagnosis. Adv Anat Pathol 2006;13:8-15.
11. McCluggage WG, Kennedy K, Busam KJ. An immunohisto-chemical study of cervical neuroendocrine carcinomas: neoplasms which are commonly TTF1 positive and which may express CK20 and p63. Am J Surg Pathol 2010;34:525-32.
12. Wang TY, Chen BF, Yang YC, et al. Histologic and immunophenotypic classification of cervical carcinomas by expression of the p53 homologue p63: a study of 250 cases. Hum Pathol 2001;32:479-86.
13. Bhargava R, Beriwal S, Dabbs DJ. Mammaglobin versus GCDFP-15: an immunohistochemical validation survey for sensitivity and specificity. Am J Clin Pathol 2007;127:103-13.
14. Onuma K, Dabbs DJ, Bhargava R. Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium. Int J Gynecol Pathol 2008;27:418-25.
15. Goldstein NS, Kestin LL, Vicini FA. Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast. Cancer 2001;92:738-47.
16. Choi YJ, Pinto MM, Hao L, et al. Interobserver variability and aberrant E-cadherin immunostaining of lobular neoplasia and infiltrating lobular carcinoma. Mod Pathol 2008; 21:1224-37.
17. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a Worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802.
18. Pirog EC, Kleter B, Olgac S, et al. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol 2000;157:1055-62.